These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 19018745

  • 1. [Vaccination scheme in advanced chronic kidney disease].
    Barril G, Teruel JL.
    Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
    [Abstract] [Full Text] [Related]

  • 2. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG, Schiff M, Graves B, Agosti J, Barritt ML, Garner D, Holley JL.
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [Abstract] [Full Text] [Related]

  • 3. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM, Gang S, Dabhi M, Kulkarni PS.
    J Nephrol; 2007 Aug; 20(5):596-601. PubMed ID: 17918146
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of a hepatitis B vaccination schedule with two cycles of four double doses of conventional vaccine and four doses of adjuvanted vaccine in chronic kidney disease patients evaluated for renal transplantation.
    García-Agudo R, Aoufi Rabih S, Araque Torres P, Dolores Fraga Fuentes M, Carlos Valenzuela Gámez J, Mancha Ramos J, María Tenías Burillo J.
    Transplant Proc; 2012 Nov; 44(9):2532-4. PubMed ID: 23146445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A, Gajda M, Pituch-Noworolska A, Drozdz M, Kraśniak A, Kaczmarczyk I, Hołyś S, Zurowski J, Sydor A, Sułowicz W.
    Przegl Lek; 2007 Nov; 64(7-8):470-5. PubMed ID: 18409347
    [Abstract] [Full Text] [Related]

  • 8. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Editorial of the "vaccination issue" of KMIL--what have demonstrated Prevenar and Fendrix vaccines].
    Beran J.
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):87-90. PubMed ID: 17051468
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.
    Przegl Epidemiol; 2007 Jun; 61(2):339-47. PubMed ID: 17956052
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.
    Vaccine; 2011 Dec 06; 29(52):9618-23. PubMed ID: 22044739
    [Abstract] [Full Text] [Related]

  • 13. A prospective study of hepatitis B vaccination - a comparison of responders versus nonresponders.
    Brown CM, Donlon S, O'Kelly P, Casey AM, Collier C, Conlon PJ, Walshe JJ.
    Ren Fail; 2011 Dec 06; 33(3):276-9. PubMed ID: 21401350
    [Abstract] [Full Text] [Related]

  • 14. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z, Mutlubaş F, Ozacar T.
    Vaccine; 2005 Apr 22; 23(22):2876-80. PubMed ID: 15780736
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
    Urbanowicz W.
    Przegl Epidemiol; 2000 Apr 22; 54(3-4):343-50. PubMed ID: 11349597
    [Abstract] [Full Text] [Related]

  • 16. Immunization status of thirty patients with sickle cell disease five years post hepatitis B vaccination. A comparison with normal controls.
    Jones-Lecointe A, Swanston WM, Charles WP, Simeon D.
    West Indian Med J; 2001 Dec 22; 50(4):317-8. PubMed ID: 11993025
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The significance of immunocompromised condition in the prophylaxis of hepatitis B in chronic renal insufficiency.
    Gasparović V, Puljević D, Gjurasin M, Delimar N, Borcić D, Gasparović H, Mihaljević I.
    Acta Med Croatica; 1993 Dec 22; 47(2):61-5. PubMed ID: 7505130
    [Abstract] [Full Text] [Related]

  • 20. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec 22; 17(98):234-6. PubMed ID: 19422145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.